Characterization of alterations in diabetic myocardial tissue using high resolution MRI

International Journal of Cardiovascular Imaging

Volumn 22, Issue 1, 2006, Pages 81-90

  Loganathan, Rajprasad ^a   Bilgen, Mehmet ^b   Al Hafez, Baraa ^b   Smirnova, Irina V ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Collagen; Fibrosis; Heart; MRI; Type 1 diabetes

Indexed keywords

COLLAGEN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BODY WEIGHT; CARDIOMYOPATHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL; HEART MUSCLE FIBROSIS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; RAT; STREPTOZOCIN DIABETES; THREE DIMENSIONAL IMAGING; TISSUE CHARACTERIZATION;

EID: 33644869870     PISSN: 15695794     EISSN: 18758312     Source Type: Journal    
DOI: 10.1007/s10554-005-5386-6     Document Type: Article

References (47)

1. KM Choi, Y Zhong, BD Hoit, IL Grupp, H Hahn and KW Dilly, Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283 (2002) H1398-408
2. CS Fox, S Coady, PD Sorlie, D Levy, JB Meigs and RB D'Agostino Sr., Trends in cardiovascular complications of diabetes. JAMA 292 (2004) 2495-2499
3. DS Bell, Diabetic cardiomyopathy. Diabetes Care 26 (2003) 2949-2951
4. KS Spector, Diabetic cardiomyopathy. Clin Cardiol 21 (1998) 885-887
5. ZY Fang, JB Prins and TH Marwick, Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications. Endocr Rev 25 (2004) 543-567
6. KC Tomlinson, SM Gardiner, RA Hebden and T Bennett, Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44 (1992) 103-150
7. YM Searls, IV Smirnova, BR Fegley and L Stehno-Bittel, Exercise attenuates diabetes-induced ultrastructural changes in rat cardiac tissue. Med Sci Sports Exerc 36 (2004) 1863-1870
8. E Riva, G Andreoni, R Bianchi, R Latini, G Luvara and G Jeremic, Changes in diastolic function and collagen content in normotensive and hypertensive rats with long-term streptozotocin-induced diabetes. Pharmacol Res 37 (1998) 233-240
9. M Kawaguchi, M Techigawara, T Ishihata, T Asakura, F Saito and K Maehara, A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels 12 (1997) 267-274
10. G Miric, C Dallemagne, Z Endre, S Margolin, SM Taylor and L Brown, Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol 133 (2001) 687-694
11. E. Adeghate, Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: A short review. Mol Cell Biochem 261 (2004) 187-191
12. L Axel, Biomechanical dynamics of the heart with MRI. Annu Rev Biomed Eng 4 (2002) 21-47
13. GJ Heatlie and K Pointon, Cardiac magnetic resonance imaging. Postgrad Med J 80 (2004) 19-22
14. SA Hayat, B Patel, RS Khattar and RA Malik, Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 107 (2004) 539-557
15. R Soler, E Rodriguez, JA Rodriguez, ML Perez and M Penas, Magnetic resonance imaging of apical hypertrophic cardiomyopathy. J Thorac Imaging 12 (1997) 221-225
16. V Hoftiezer and AM Carpenter, Comparison of streptozotocin and alloxan-induced diabetes in the rat, including volumetric quantitation of the pancreatic islets. Diabetologia 9 (1973) 178-184
17. MJ Mihm, JL Seifert, CM Coyle and JA Bauer, Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model. Life Sci 69 (2001) 527-542
18. SL Jeffcoate, Diabetes control and complications: The role of glycated haemoglobin, 25 years on. Diabet Med 21 (2004) 657-665
19. GN Pierce and NS Dhalla, Heart mitochondrial function in chronic experimental diabetes in rats. Can J Cardiol 1 (1985) 48-54
20. M Grover-McKay, TD Scholz, TL Burns and DJ Skorton, Myocardial collagen concentration and nuclear magnetic resonance relaxation times in the spontaneously hypertensive rat. Invest Radiol 26 (1991) 227-232
21. TD Scholz, SR Fleagle, TL Burns and DJ Skorton, Nuclear magnetic resonance relaxometry of the normal heart: Relationship between collagen content and relaxation times of the four chambers. Magn Reson Imaging 7 (1989) 643-648
22. IL Cameron, VA Ord and GD Fullerton, Characterization of proton NMR relaxation times in normal and pathological tissues by correlation with other tissue parameters. Magn Reson Imaging 2 (1984) 97-106
23. KH van Hoeven and SM Factor, A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 82 (1990) 848-855
24. S Chen, T Evans, K Mukherjee, M Karmazyn and S Chakrabarti, Diabetes-induced myocardial structural changes: Role of endothelin-1 and its receptors. J Mol Cell Cardiol 32 (2000) 1621-1629
25. ML Gross, N Heiss, M Weckbach, A Hansen, A El-Shakmak and A Szabo, ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes. Diabetologia 47 (2004) 316-324
26. FJ Ramires, Y Sun and KT Weber, Myocardial fibrosis associated with aldosterone or angiotensin II administration: Attenuation by calcium channel blockade. J Mol Cell Cardiol 30 (1998) 475-483
27. FL Norby, LE Wold, J Duan, KK Hintz and J Ren, IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol Metab 283 (2002) E658-666
28. F Sardanelli, G Molinari, A Petillo, C Ottonello, RC Parodi and MA Masperone, MRI in hypertrophic cardiomyopathy: A morphofunctional study. J Comput Assist Tomogr 17 (1993) 862-872
29. M. Fisher, Diabetes and atherogenesis. Heart 90 (2004) 336-340
30. AI Al-Shafei, RG Wise, GA Gresham, G Bronns, TA Carpenter and LD Hall, Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats. J Physiol 538 (2002) 541-553
31. AI Al-Shafei, RG Wise, GA Gresham, TA Carpenter, LD Hall and CL Huang, Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: The effect of angiotensin-converting enzyme inhibition. J Physiol 538 (2002) 555-572
32. EW Remme, AA Young, KF Augenstein, B Cowan and PJ Hunter, Extraction and quantification of left ventricular deformation modes. IEEE Trans Biomed Eng 51 (2004) 1923-1931
33. V Pelouch, IM Dixon, L Golfman, RE Beamish and NS Dhalla, Role of extracellular matrix proteins in heart function. Mol Cell Biochem 129 (1993) 101-120
34. TJ Regan, N Altszuler, C Eaddy and S Bakth, Relation of growth hormone and myocardial collagen accumulation in experimental diabetes. J Lab Clin Med 110 (1987) 274-278
35. M Shimizu, K Umeda, N Sugihara, H Yoshio, H Ino and R Takeda, Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 46 (1993) 32-36
36. VI Kapelko, VI Veksler, MI Popovich and R Ventura-Clapier, Energy-linked functional alterations in experimental cardiomyopathies. Am J Physiol 261 (1991) 39-44
37. S Vinitski, MG Pearson, SJ Karlik, WK Morgan, LS Carey and G Perkins, Differentiation of parenchymal lung disorders with in vitro proton nuclear magnetic resonance. Magn Reson Med 3 (1986) 120-125
38. M Sundaram, MH McGuire and F Schajowicz, Soft-tissue masses: Histologic basis for decreased signal (short T2) on T2-weighted MR images. Am J Roentgenol 148 (1987) 1247-1250
39. J Johansen, F Taagehoj, T Christensen, J Overgaard and M Overgaard, Quantitative magnetic resonance for assessment of radiation fibrosis after post-mastectomy radiotherapy. Br J Radiol 67 (1994) 1238-1242
40. S Sandmann, RM Bohle, T Dreyer and T Unger, The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats. Virchows Arch 436 (2000) 147-157
41. D Grimm, HC Jabusch, P Kossmehl, M Huber, S Fredersdorf and DP Griese, Experimental diabetes and left ventricular hypertrophy. Effects of beta-receptor blockade. Cardiovasc Pathol 11 (2002) 229-237
42. M Lassila, BJ Davis, TJ Allen, LM Burrell, ME Cooper and Z Cao, Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system. Clin Sci (Lond) 104 (2003) 341-347
43. A Sato, L Tarnow and HH Parving, Increased left ventricular mass in normotensive type 1 diabetic patients with diabetic nephropathy. Diabetes Care 21 (1998) 1534-1539
44. K Alfakih, S Reid, T Jones and M Sivananthan, Assessment of ventricular function and mass by cardiac magnetic resonance imaging. Eur Radiol 14 (2004) 1813-1822
45. F Grothues, JC Moon, NG Bellenger, GS Smith, HU Klein and DJ Pennell, Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 147 (2004) 218-223
46. SE Slawson, BB Roman, DS Williams and AP Koretsky, Cardiac MRI of the normal and hypertrophied mouse heart. Magn Reson Med 39 (1998) 980-987
47. M Bilgen, Simple, low-cost multipurpose RF coil for MR microscopy at 9.4 T. Magn Reson Med 52 (2004) 937-940